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Abstract
Introduction: Bronchoalveolar	lavage	(BAL)	is	used	in	the	diagnosis	of	interstitial	lung	diseases.	BAL	is	diagnostic	when	≥	60%	
of	the	instilled	volume	is	recovered.	There	are	no	reliable	markers	useful	to	predict	whether	BAL	volume	is	going	to	be	diagnostic.	
Our	goal	was	to	search	for	pulmonary	function	markers	which	could	anticipate	whether	the	recovered	volume	of	instilled	fluid	
would	be	≥	60%	of	administered	volume.
Material and methods: BAL	volumes	and	quality	were	analyzed	in	the	context	of	disease,	medical	condition	and	lung	function	
test	results	of	the	subjects	hospitalized	at	the	Pulmonology	Ward	from	January	2015	to	October	2016.	The	patients’	average	age	
was	61	(29–89).
Results: Among	80	procedures,	diagnostic	BAL	(≥	60%)	has	been	obtained	in	58	cases.	The	analysis	of	the	group	of	patients	with	
an	interstitial	lung	disease	confirmed	that	there	is	a correlation	between	decreasing	BAL	recovered	volume	and	an	increase	of	
RV[%pred]	(r	=	–0.34)	and	RV/TLC[%pred]	(r	=	–0.41);	p	<	0.05.	There	was	no	significant	correlation	with	DLCO.	RV/TLC[%pred]	
was	the	parameter	with	the	highest	predictive	value	for	an	anticipated	correct	BAL	recovery.	The	curve	analysis	of	the	receiver	
operating	characteristic	(ROC)	showed	a diagnostic	accuracy	(AUC 0.73,	95%	CI	0.61–0.86).
Conclusions:	Pulmonary	hyperinflation	may	have	a predictive	role	in	anticipating	a proper	recovery	of	the	BAL	fluid	volume.	
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Introduction
Interstitial lung diseases (ILDs) constitute 
a very heterogeneous group of non-infectious 
and non-cancerous illnesses, which includes 
more than 200 disease entities of a similar clini-
cal, radiological and pathophysiological picture 
[1, 2]. Individual disease entities do not occur 
very often, but all ILDs account for about 16% 
of the respiratory system diseases [2]. It means 
that their correct diagnosis, differentiation 
and, consequently, effective treatment are an 
essential task for physicians.
The main changes in ILDs are hypoxia during 
rest and/or during exercise, bilateral pulmonary 
disseminated lesions on thoracic imaging and 
a restrictive pulmonary disorder with an abnor-
mal gas transfer [3]. 
The diagnostic approach includes: clinical 
history and examination, pulmonary function 
tests, selective blood tests, imaging examinations: 
chest radiography and high resolution computed 
tomography, bronchoscopy with bronchoalveolar 
lavage (BAL) and/or endobronchial/transbron-
chial biopsies and/or a surgical biopsy [4]. 
The essence of the disease process in the 
course of ILDs are lesions in the peripheral 
structures of the respiratory system. A medical 
procedure that allows to obtain material from the 
bronchoalveolar space is BAL performed during 
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bronchoscopy. It is characterized by low invasi-
veness and high safety [5]. 
The fluid obtained during this procedure 
can be used in the research and the diagnostic 
processes only if the procedure has been carried 
out in compliance with the guidelines. One of 
the primary condition is the recovery of 50–70% 
of the volume of fluid introduced during the 
procedure [6]. It is believed that in addition to its 
usage in the diagnostic process, BAL can replace 
other, more invasive examinations useful for the 
long-term monitoring of the disease activity [1]. 
Since the 1990s there has been an ongoing process 
directed to standardize each stage of broncho-
alveolar lavage [3, 6–10]. 
A  variety of clinical situations that may 
reduce the volume of the recovered fluid have 
been identified. These include old age, cough, 
smoking and emphysema [11–13]. However, there 
are no parameters or tests that would allow us to 
predict before performing bronchoscopy whether 
the obtained material will have the researching 
and diagnostic value. The identification of such 
predictors might help extract methods allowing 
for increased BAL fluid recovery, and then their 
use in patients without the risk of obtaining 
a non-diagnostic result of BAL.
The aim of the research was to find spiro-
metric, plethysmographic and lung diffusion 
parameters, which could become predictors for 
achieving the ≥ 60% volume of the fluid admini-
stered during bronchoalveolar lavage.
Material and methods
Study group
The retrospective analysis included the 
patients with interstitial lung disease from the 
Department of Pneumonology who have undergo-
ne BAL procedure in the period between January 
2015 and October 2016.
The study group consisted of 80 people 
(44 women and 36 men) aged between 29–89 (ave-
rage age 61.4 ± 12.15). The patients were divided 
into two groups: those who did not demonstrate 
correct recovery (Group 1) and those with correct 
recovery (Group 2).
Bronchoscopy with BAL
The bronchofiberoscopy with BAL took place 
after obtaining written consent of patients. All 
procedures were performed under local airway 
anaesthesia (1% lignocaine solution) after pre-
medication (midazolam with or without the 
addition of tramadol). Lavage was carried out in 
segments 4 or 5 of either right or left lung or in 
the area with the most severe interstitial lesions 
confirmed by medical imaging. If the lesions were 
evenly spread, the lavage was performed in the 
bronchi of the middle lobe or uvula based on the 
voluntary decision of a physician.
BAL was performed in accordance with the 
recommendation of the Polish Respiratory Society 
for bronchoalveolar lavage (BAL) sampling, pro-
cessing and analysis methods [6].
During the procedure, 200 mL of 37ºC; 0.9% 
sodium chloride solution was applied in 25 ml 
fractions. 
Lung function tests
All procedures have been carried out in the 
Laboratory of Functional Testing of the Respirato-
ry System at the Department of Pneumonology by 
qualified medical personnel before bronchoscopy 
performance. The spirometry test, plethysmo-
graphic measurement of lung volumes and me-
asurement of lung diffusion capacity for carbon 
monoxide were performed using (MasterLab, 
Jaeger, Germany). 
All procedures were carried out in accordance 
with the Guidelines of the Polish Respiratory Society 
concerning the performance of spirometry tests [14]. 
Statistical analysis
The obtained data was subjected to stati-
stical analysis using Statistica 13.1 tool. The 
Mann-Whitney U Test and chi-squared test were 
applied to calculate the differences between the 
groups. The analysis of the correlation between 
age and the results of lung function tests and BAL 
fluid recovery was determined using the Pearson 
correlation coefficient and Spearman’s rank cor-
relation coefficient depending on the distribution 
type of compared variables. For parameters that 
demonstrate statistically significant correlations, 
their predictive ability to obtain the correct vo-
lume of fluid recovery during bronchoalveolar 
lavage was tested. For this purpose, the area under 
receiver operating characteristic (ROC) curves 
were determined. The level of significance p < 
0.05 was adopted as statistically significant.
Results
The average values of all parameters measu-
red during lung function tests were reduced. The 
nearest value to the normal one was shown by the 
pulmonary distension indicator RV/TLC[%pred].
According to the specificity of interstitial 
lung diseases, the largest reduction to the para-
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meters based on lung diffusion capacity was also 
noted in this study. 
The average fluid recovery from broncho-
alveolar lavage was 64% (128 ml). 
In 58 cases (72.5%), this recovery amounted 
to ≥ 60%.
Table 1 shows differences between the lung 
function parameters in Group 1 (without correct 
recovery) and Group 2 (with correct recovery).
All spirometry parameters and those based on 
lung diffusion capacity were reduced in Group 1, 
but only in some of them, the difference turned 
out to be statistically significant. On the other 
hand, parameters measured during plethysmo-
graphy were lower in the group with the correct 
recovery.
For each of the studied parameters in lung 
function tests, the correlation between their value 
and percentage recovery of BAL fluid was calcu-
lated. Correlations for RV[%pred] (r = –0.34; p = 
0.003) and RV/TLC[%pred] (r = –0.41; p < 0.001) 
were statistically significant.
Correlations between the recovery and the 
patients’ age were not demonstrated.
In order to evaluate the usefulness of these 
parameters as predictors of correct BAL fluid 
recovery, ROC curves were determined for them. 
Bronchoalveolar lavage retrieval was classified as 
a dichotomous variable, while as a cut-off point 
for correct recovery, the value of ≥ 60% of the 
given fluid volume was adopted. 
Continuous predictors in compliance with 
the direction of previously calculated correlations 
were classified as destimulants (RV[%pred] and 
RV/TLC[%pred]) to achieve the diagnostic results 
of BAL. A parameter featuring the greatest accu-
racy of the model matching is RV/TLC[%pred], 
for which AUC = 0.73 (95% CI [0.60–0.85]) p = 
0.002. ROC curves for RV/TLC[%pred] are shown 
in Figure 1.
Table 1. Comparison of the patients with and without correct BAL recovery
Parameter Total Group 1
(without correct recovery)
Group 2
(with corect recovery)
p-value
n Mean ± SD n Mean ± SD n Mean ± SD
Age 80 61.4	±	12.2 22 61.1	±	11.7 58 61.5	±	12.4 0.78
Sex	(Male/Female) 36/44 10/12 26/32 0.96
FEV1/FVC 78 80.2	±	9.8 20 78.8	±	9.8 58 81.9	±	7.4 0.10
FEV1[%pred]	 78 85.5	±	23.8 20 80.1	±	21.7 58 89.2	±	22.5 0.11
FVC[%pred] 78 86.7±	23.6 20 84.0	±	25.5 58 88.6	±	22.7 0.53
TLC[%pred] 71 83.0	±	19.4 20 85.7	±	22.1 51 81.9	±	18.4 0.60
ITGV[%pred] 71 88.2	±	22.9 20 95.8	±	21.4 51 85.3	±	22.9 0.08
RV[%pred] 71 83.5	±	26.9 20 96.2	±	30.3 51 78.6	±	24.1 0.02
RV/TLC[%pred] 71 97.0	±	20.8 20 108.7	±	18.9 51 92.5	±	19.9 0.002
DLCO[%pred] 76 63.9	±	23.6 21 57.7	±	24.2 55 66.2	±	23.1 0.13
DLCO/VA[%pred] 76 79.3	±	19.6	 21 72.3	±	18.7 55 82.0	±	19.5 0.09
*Mann-Whitney	U	test	or	chi-squared	test:	FEV1:	forced	expiratory	volume	in	1	second;	FVC:	forced	vital	capacity;	TLC:	total	lungs	capacity;	ITGV:	intrathoracic	residual	
volume;	RV:	residual	volume;	DLCO:	diffusing	capacity	of	the lungs for carbon	monoxide;	VA:	alveolar	volume;	%	pred:	percentage	of	predicted	values;	p:	probability	
in	the	test	of	significance
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Figure 1.	ROC	curves	for	RV/TLC[%pred]	RV/TLC	[%pred];	AUC	0.73,	–95%	
CI	0.60;	+95%	CI	0.85;	Value	p	=	0.002.	RV:	residual	volume;	TLC:	total	
lungs	capacity;	%	pred:	percentage	of	predicted	values;	AUC:	area	under	
curve;	CI:	confidence	interval;	p:	probability	in	the	test	of	significance
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Discussion
To the best of our knowledge, we have shown 
for the first time that RV/TLC may be predictive 
in terms of whether BAL volume could be diagno-
stic. Bronchoalveolar lavage plays an important 
role in the differential diagnosis of interstitial 
lung diseases [3, 6]. Moreover, it can be used 
in the diagnosis of inflammatory diseases and 
infections, which is especially important in im-
munocompromised patients [15]. BAL may help 
in obtaining diagnosis and may be used for chan-
ging the management of immunocompromised 
patients. Furthermore, it may result in respiratory 
failure exacerbation, which may cause hypoxemia 
leading even to intubation [16]. We have shown 
that in the future it may be possible to predict on 
the basis of the pulmonary function test whether 
BAL will be diagnostic in terms of salvage volume. 
In clinical practice, there are cases in which 
it is impossible to recover the right volume of BAL 
fluid. There are some scientific reports that show 
attempts to find reasons for reduced BAL rega-
ining [11–13]. A correlation between age and re-
duced recovery has been demonstrated so far [12]. 
However, the results of our study do not confirm 
this correlation. This may be because the pre-
vious study has been based on carrying out BAL 
procedure on healthy individuals [12]. As people 
get older, the lung tissue elasticity decreases. Low 
lung elasticity affects the recovery volume. Mean-
while, our study involves patients with interstitial 
lung diseases in which lesions present in the lung 
tissue are less dependent on age and more on the 
severity of the disease process.
In a study of patients with chronic obstruc-
tive pulmonary disease (COPD) carried out by 
Löfdahl et al. [13], a  relationship between re-
duced recovery and the severity of emphysema 
was shown, which was measured as an index 
of distension in HRCT. Our research confirms 
the dependence of recovery on the severity of 
emphysema, but it is worth bearing in mind that 
the degree of pulmonary distension was measu-
red using plethysmographic parameters. An in-
crease in RV[%pred] as well as RV/TLC[%pred] 
ratio negatively correlated with the volume of 
recovered BAL fluid. However, this relationship 
has proved to be of less importance than that 
associated with pulmonary distension DLCO. 
The same publication demonstrated a modera-
tely positive correlation between recovery from 
BAL and lung diffusion capacity for carbon mo-
noxide [13]. This relationship was not detected 
in our study. The reason for this difference can 
be probably explained by different histological 
pattern of pulmonary parenchyma in interstitial 
lung diseases and COPD. While in the case of 
ILDs, the degree of DLCO impairment does not 
correlate with the severity of pathological le-
sions. Extensive areas of fibrosis in the course 
of ILDs are not always reflected in impaired lung 
diffusion capacity, while a significant reduction 
in lung volume and severe hypoxemia have no 
correlation with a  considerable reduction of 
DLCO [17].
One of the factors which influence BAL salva-
ge is the area where it was performed. The volume 
of the recovered fluid is the highest when lavage 
is performed in the bronchi of the middle lobe or 
lingula [18]. Therefore, the procedure is usually 
performed in the middle and lingual lobe unless 
local abnormalities justify BAL performance in 
different segments. However, this has not played 
any role in our results because included patients 
have had BAL collected from the segment 4 and 5 
bilateral. On the other hand, there is an increasing 
number of indications to perform various forms of 
BAL in other segments than only 4–5. This may be 
especially important in therapeutic lavage such as 
the one performed in pulmonary proteinosis [19], 
however, therapeutic BAL was not a subject of 
analysis in the present study.
Conclusions
RV/TLC [%pred] seems to have the highest 
predictive value for the anticipated correct BAL 
recovery. However, on the basis of retrospective 
data, it is impossible to indicate a good cutoff po-
int for sensitive and specific prediction whether 
BAL salvage will be diagnostic. Therefore, it is 
necessary to perform a multicenter randomized 
controlled trial, in order to verify our observation 
and find an accurate cutoff point, which would 
discriminate between BAL salvage ≥ and < 60%. 
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